Ninety-day Readmission and Long-Term Mortality in Medicare Patients (≥65 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium)

Ticagrelor and prasugrel were found to be superior to clopidogrel for the treatment of acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI); however, the comparative effectiveness of these 2 drugs remains unknown. We compared post-discharge outcomes among older patients treat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cardiol
Autors principals: Song, Chris, Sukul, Devraj, Seth, Milan, Dupree, James M., Khandelwal, Akshay, Dixon, Simon R., Wohns, David, LaLonde, Thomas, Gurm, Hitinder S.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850017/
https://ncbi.nlm.nih.gov/pubmed/29025684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2017.08.009
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars